Rchr
J-GLOBAL ID：201401044712131239   Update date: Jan. 30, 2024

Serizawa Kentaro

セリザワ ケンタロウ | Serizawa Kentaro
Affiliation and department：
Kindai University Faculty of Medicine

About Kindai University Faculty of Medicine


Research field  (1)： Hematology and oncology
Research theme for competitive and other funds  (1)：
  • 2023 - 2026 変異受容体型チロシンキナーゼの細胞内輸送制御による白血病治療薬の開発研究
Papers (29)：
  • Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii, Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, et al. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma. Journal of clinical and experimental hematopathology : JCEH. 2023. 63. 2. 99-107
  • Ryosuke Fujiwara, Yasuhiro Taniguchi, Shinya Rai, Yoshio Iwata, Aki Fujii, Ko Fujimoto, Takahiro Kumode, Kentaro Serizawa, Yasuyoshi Morita, J Luis Espinoza, et al. Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells. Biochemical and biophysical research communications. 2022. 626. 156-166
  • Takahiro Kumode, Hirokazu Tanaka, Jorge Luis Esipinoza, Shinya Rai, Yasuhiro Taniguchi, Ryosuke Fujiwara, Keigo Sano, Kentaro Serizawa, Yoshio Iwata, Yasuyoshi Morita, et al. C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis. International journal of hematology. 2022. 115. 3. 310-321
  • Kentaro Serizawa, Hirokazu Tanaka, Takeshi Ueda, Ayano Fukui, Hiroaki Kakutani, Takahide Taniguchi, Hiroaki Inoue, Takahiro Kumode, Yasuhiro Taniguchi, Shinya Rai, et al. CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence. International Journal of Hematology. 2022. 115. 3. 336-349
  • Shinya Rai, Hiroaki Inoue, Kazuko Sakai, Hitoshi Hanamoto, Mitsuhiro Matsuda, Yasuhiro Maeda, Takahiro Haeno, Yosaku Watatani, Takahiro Kumode, Kentaro Serizawa, et al. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. Cancer science. 2022. 113. 2. 660-673
ｍore...
MISC (19)：
  • 田中 宏和, 芹澤 憲太郎, 松村 到. 【多発性骨髄腫update-診断・治療の最新動向-】病態 骨髄腫進展の細胞遺伝学的病態. 日本臨床. 2023. 81. 6. 806-812
  • 田中 宏和, 芹澤 憲太郎, 松村 到. 再発・抵抗性多発性骨髄腫におけるcell-free DNAの意義. 血液内科. 2023. 86. 2. 266-271
  • 田中宏和, 芹澤憲太郎, 松村到. Recent trends in basic research on myeloma initiating cells. 月刊血液内科. 2022. 84. 4
  • 口分田貴裕, 頼晋也, 波江野高大, 角谷宏明, 源周治, 綿谷陽作, 芹澤憲太郎, 谷口康博, 森田泰慶, 田中宏和, et al. Gilteritinib treatment for extramedullary relapse of FLT3-ITD acute myeloid leukemia. 日本造血細胞移植学会総会プログラム・抄録集. 2021. 43rd
  • 谷口康博, 平瀬主税, 芦田隆司, 波江野高大, 角谷宏明, 源周治, 綿谷陽作, 口分田貴裕, 芹澤憲太郎, 頼晋也, et al. Clinical usefulness of Letermovir for patients with stem cell transplantation. 日本造血細胞移植学会総会プログラム・抄録集. 2021. 43rd
ｍore...
Lectures and oral presentations  (41)：
  • 十二指腸原発濾胞性リンパ腫における抗腫瘍免疫の寄与
    (日本リンパ網内系学会会誌 2019)
  • 末梢血幹細胞採取前のCD34細胞数測定の有用性
    (日本アフェレシス学会雑誌 2018)
  • KMFに登録されたボルテゾミブとIMiDs両剤に抵抗性の再発骨髄腫の予後解析(Clinical outcomes of relapsed myeloma, dual refractory to bortezomib and IMiDs in KMF registry)
    (臨床血液 2018)
  • 骨髄異形成症候群に合併したSweet病に対するアザシチジンの免疫学的効果(Immunological effects of azacitidin on Sweet's disease associated with myelodysplastic syndromes)
    (臨床血液 2018)
  • CD34陽性ヒト骨髄腫幹細胞の同定と特性解析(Identification and characterization of CD34+ myeloma cell population as myeloma-initiating cells)
    (臨床血液 2018)
ｍore...
Education (1)：
  • - 現在 Kindai University Faculty of Medicine
Professional career (1)：
  • 医学博士 (近畿大学大学院医学研究科医学系専攻)
Work history (1)：
  • - 現在 Kindai University Faculty of Medicine
Association Membership(s) (6)：
THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY ,  THE JAPANESE ASSOCIATION FOR INFECTIOUS DISEASES ,  日本造血細胞移植学会 ,  日本臨床腫瘍学会 ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM